Available Soon: 3X Genetics has developed a diagnostic test platform to service to patients and medical professionals. This platform offers low-cost diagnosis of GRE diseases, starting with Myotonic Dystrophy.  3X Genetics uses certified PCR-Based testing to diagnose GRE diseases, followed by nanopore sequencing to accurately determine the composition of long nucleotide repeat expansions.

Under Development: To ultimately facilitate large-scale patient discovery via general population testing, 3X Genetic’s world-class science team is developing targeted genetic sequencing (TGS) test methods to crush test costs and improve test accuracy.